Page 2 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We will begin with campaign 2014 and the tone of this election cycle. What is it like in your state . You can send us a tweet or join the conversation on facebook. Start dialing in now. The National Journal has this headline on their website. Not, politicalr ads have been more negative than ever. A recent study shows that an u. S. Senate races, 55 of ads over the last two weeks were onlyive, which means they criticize the opponent, another 17. 5 were contract ads, ads that mentioned both the opponent and the sponsored favorite candidate. As for gubernatorial and house races over that. Frome th...

Issues such as revamping the tax code and reducing deficits, but he signalled split decisions in an era of divided government. Progress does not compel us to settle. Centuries long debates about the role of government for all time, but it does require us to act in our time. [applause] for now decisions are upon us. And we cannot afford to wait. We cannot mistake absolutism for principle or substitute spectacle for politics or treat name calling as reasoned debate. [applause] we must act. We must act knowing that our work will be unperfect. We must act knowing that todays victories will be only...

St. Paul, MN, May 29, 2024 – ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced the launch of the G-Rex® Grant Program, a $20 million initiative to propel the advancement of cell and gene-modified cell therapies (CGT). The G-Rex® Gran...

MINNEAPOLIS, May 22, 2024 /PRNewswire/ -- Bio-Techne Corporation and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines...

Bio-Techne (NASDAQ:TECH – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Risk and Volatility Bio-Techne has a beta of 1.23, […]